COMMENTARY
Where Science Meets Culture: The Art of Health Diplomacy
by Dr. Jorge Gomez
In this special issue of the NCI Cancer Bulletin, you will read about some of the ways NCI is supporting international collaboration for research, training, communications, and other activities related to understanding cancer and treating patients who have cancer, as well as providing information to those who may be at high risk for developing it. These collaborations are critical to our success—cancer is a problem so immense that we must gather all the ideas so that we can confront the disease in the most comprehensive way possible. Read more > >
NEWS
In Bangladesh, Developing Models for Cancer Care
In early November, Dr. Richard Love traveled from his home in Wisconsin to Khulna, Bangladesh, where he is working to develop a radiation therapy center for people with cancer. The trip included a visit to a free breast health clinic that his organization, the International Breast Cancer Research Foundation (IBCRF), and its local partners created nearly 4 years ago in Bagerhat, in southwestern Bangladesh. Read more > >
The Cancer Expert Corps: An Idea for Building Human Capital
This program aims to address the "brain drain" that plagues low-resource countriesCancer Communicators in Latin America Get Support at NCI Workshop
Media relations officials and journalists met to discuss best practicesConsidering Culture When Providing Cancer Care
Middle East Cancer Consortium is building the capacity for palliative care and related research
NCI's International Cancer Research Resources
Find resources by topic and region
HIGHLIGHTS
SUPPLEMENT TO THE SPECIAL ISSUE
Prostate Cancer Hormone Treatments May Raise Risk of Colorectal Cancer
Risk increased about 20 to 40 percent in men who took gonadotropin-releasing hormone agonistsStrategy to Screen for Lynch Syndrome May Save Lives and Be Cost Effective
Approach reduces incidence of several cancers in those with hereditary syndromeAnemia Drug May Interfere with Trastuzumab's Anticancer Effects
Recombinant human erythropoietin appears to reactivate pathway that allows cancer cells to growPossible Causes of Resistance to Melanoma Drug Reported
Two studies suggest mechanisms that may cause PLX4032 to stop workingRadiation Treatment for Head and Neck Cancer May Produce Hearing Loss
Loss of hearing function can be significant and harm quality of life
UPDATES
SUPPLEMENT TO THE SPECIAL ISSUE
FDA Update
- Another Option Added for Treating Late-Stage Breast Cancer
- Denosumab Approved to Prevent Bone Problems in Cancer Patients
CMS Update
- Medicare Advisory Panel Reviews Data on Provenge
Cancer.gov Update
- New Content on NCI's YouTube Network
- NCI Recovery Act Web Site Highlights NCI's Smoking Cessation Program
Notes
- In Memoriam: Dr. Elaine Ron, Senior Investigator in DCEG
- EEMS Accepting Proposals for Use of PLCO Data and Biospecimens
- Next NCAB Meeting Scheduled for December 7
- President's Cancer Panel Discusses the Future of Cancer Research
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
